What is thrombolytic therapy?

thrombolytic therapy is a medical treatment used after many strokes or infarctions or other evidence of huge blood clots to remove clots. This type of therapy is based on a drug and certain drugs are administered intravenously (IV) or can be administered by catheterization. The aim is to quickly get rid of any blood clot or thrombus, restore function into an area that is influenced by it, such as heart, brain or limb.

Another term for thrombolytic therapy is the precipitate of the clot, and this is a good description of what happens when this therapy is used. Emphasis is placed on the clots to be removed very quickly by breaking them. Their continuing presence can have such a deeply dangerous effect that treatment is immediately required. Most people who have thrombolytic therapy will have it within two hours of receiving to the hospital. The bridge in common is called tissue plasminogen activator (TPA). Other medicines may be considered to include streptokinázu. Some of them, as the names would suggest, are made of bacteria. Each drug used for thrombolytic therapy can function in a slightly different way and one can be considered more appropriate than another depending on the circumstances.

All these drugs try to dissolve or break the clot so that medicines like aspirin cannot work. Aspirin is commonly recommended to those who suffer from a heart attack and can prevent an increase in a blood clot. It is not considered to be sufficiently effective, because it still cannot replace thrombolytic therapy. Cannot reduce the size of the clot that already exists.

There is significant evidence that thrombolytic therapy can increase survival and minimize heart damage if people get this therups soon after a heart attack. As already mentioned, many people accept it shortly after admission to the hospital. Agencies like American Heart Association RecommendIt is used by its use within 12 hours of a heart attack. If a stroke has occurred, greater urgency is required, as brain damage may occur so quickly.

It is not advisable to provide this therapy in all cases. If people have a hemorrhagic stroke where a blood vessel has been torn in the brain, there is an extreme risk if thrombolytic therapy is used. It can seriously increase bleeding and endanger life. Although this therapy is used, it can cause excessive bleeding and it can also be life -threatening.

Sometimes a reaction to this therapy is a hemorrhagic stroke, but it is estimated that this occurs only in about 1%. Approximately one of four people has some bleeding, while treatment is taking place, usually made of mucus membranes, such as mouth and nose. This should be alerted to doctors.